To stimulate immune activation in Th-MYCN model, we primed the tumor microenvironment by administering the copper chelating agent TEPA daily for 1 week, followed by the addition of twice weekly doses of anti-GD2 antibody (Fig. 1a). This evidence concerns the gene MYCN and neoplasm.